Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.
This report contains market size and forecasts of ADHD Treatment in global, including the following market information:
Global ADHD Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global ADHD Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five ADHD Treatment companies in 2021 (%)
The global ADHD Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ADHD Treatment include Takeda, Johnson & Johnson, N ovartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and N oven Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADHD Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ADHD Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ADHD Treatment Market Segment Percentages, by Type, 2021 (%)
Stimulant
Non-stimulant
Global ADHD Treatment Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ADHD Treatment Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Global ADHD Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ADHD Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ADHD Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies ADHD Treatment revenues share in global market, 2021 (%)
Key companies ADHD Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies ADHD Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Johnson & Johnson
N ovartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
N oven Pharmaceuticals
Purdue Parma
Jiangsu Chia Tai Fenghai Pharmaceutical